Clinical trial
Clinical Evaluation of the 3 Allergens: Methyldibromoglutharonitrile…
NCT00133341 · Mekos Laboratories AS, Industry · Completed
Key facts
| NCT number | NCT00133341 |
|---|---|
| Title | Clinical Evaluation of the 3 Allergens: Methyldibromoglutharonitrile, Parthenolide and Goldnatriumthiosulphate |
| Official title | Clinical Evaluation of the 3 Allergens: Methyldibromoglutharonitrile, Parthenolide and Goldnatriumthiosulphate for "TRUE Test® Panel 3" - a Phase II, Dose-Response Study. |
| Lead sponsor | Mekos Laboratories AS, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Allergic Contact Dermatitis |
| Intervention type | Drug |
| Interventions | Goldnatriomthiosulphate, MDBGN, parthenolide |
| Enrollment | 60 |
| Start date | Apr 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Aug 23, 2005 |
| Last update posted | Feb 27, 2006 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: